Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

AAL vs SIGA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AAL Captures Overall Composite Edge (48.7 HOLD vs 47.5 HOLD), While SIGA Leads 4–2 on Growth & Valuation Pillars

AAL Overall Winner 6-Pillar Tally: AAL 2 – 4 SIGA Matrix Metrics: AAL 7 – 3 SIGA

As of Nov 19, 2026, American Airlines Group Inc. (AAL) captures the overall head-to-head institutional edge over SIGA Technologies Inc. (SIGA) on higher Unified Composite conviction (48.7/100 HOLD vs. 47.5/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples, Growth & Scale), while SIGA wins 4–2 across the 6-pillar growth and valuation breakdown. AAL trades at $12.72 (12.5x Forward P/E, 1.8% operating margin) versus SIGA at $2.65 (2.5x Forward P/E, -14.2% operating margin).

  • Growth vs. Quality Trade-Off: AAL earns the overall head-to-head edge with a stronger Unified Composite Score (48.7/100 HOLD vs. SIGA 47.5/100 HOLD) and 1.82β · 52% Vol risk profile, whereas SIGA leads top-line expansion (-49.7% YoY revenue growth, 3.37x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: AAL is currently in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 46.6); meanwhile SIGA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AAL vs SIGA
AAL NASDAQ Head-to-Head Winner
American Airlines Group Inc.
Air Transportation, Scheduled
$12.72
-2.23% 1D
Market Cap $8.6B
TTM Revenue $61.0B
Forward P/E 12.5x
Beta / 30D Vol 1.82β · 52% Vol
Unified Composite Score
48.7 / 100 HOLD
Tech 48.0 Fund 50.0 Flow 57.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -1.7%) with fading momentum, RSI 47
RSI-14: 46.6 · SMA20: $13.07 · SMA50: $12.94
SIGA NASDAQ
SIGA Technologies Inc.
Pharmaceutical Preparations
$2.65
-5.36% 1D
Market Cap $187.9M
TTM Revenue $52M
Forward P/E 2.5x
Beta / 30D Vol 0.75β · 65% Vol
Unified Composite Score
47.5 / 100 HOLD
Tech 40.0 Fund 56.0 Flow 69.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -0.7%), weak momentum, RSI 36
RSI-14: 36.0 · SMA20: $3.02 · SMA50: $3.14

6-Pillar Scorecard Institutional Category Breakdown (AAL 2 – 4 SIGA)

Columns: Metric · AAL · SIGA
1. Valuation Multiples AAL
Forward P/E 12.5x 2.5x
Trailing P/E 11.1x N/M
PEG Ratio 0.21x 3.37x
EV / Revenue 0.7x 1.4x
2. Growth & Scale AAL
Revenue Growth (YoY) +19.3% -49.7%
Earnings Growth (YoY) -88.2% -65.3%
TTM Revenue (USD) $61.0B $52M
Market Cap $8.6B $187.9M
3. Profitability & Quality SIGA
Gross Margin 20.8% 23.4%
Operating Margin 1.8% -14.2%
Net Profit Margin -0.8% 1.3%
Return on Equity (ROE) 0.0% 0.4%
4. Balance Sheet & Cash Flow SIGA
Cash Generation (TTM) -$91M -$12M
Cash Flow Margin -0.1% -22.1%
Net Cash / Leverage $36.1B Net Debt $116M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning SIGA
Options Structure Phase BREAKDOWN CONSOLIDATION
Current IV / %ile 59.8% (21st %ile) 81.4% (8th %ile)
Put/Call OI Skew 1.38x (Put-Skewed) 0.04x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Distribution DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat SIGA
OpEx & R&D Intensity 19.0% of Rev ($11.6B) 37.6% of Rev ($20M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Airlines Operator Drug Manufacturers - Specialty & Generic Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AAL (7) vs SIGA (3)
Institutional Metric AAL SIGA Criterion Row Edge
Market Capitalization
Scale
$8.6B $187.9M Larger Scale AAL
Trailing P/E Ratio
Valuation
11.1x N/M Lower Multiple AAL
Forward P/E Ratio
Valuation
12.5x 2.5x Lower Multiple SIGA
Revenue Growth (YoY)
Growth
+19.3% -49.7% Higher Growth AAL
Operating Margin (TTM)
Profitability
1.8% -14.2% Higher Margin AAL
Net Profit Margin
Profitability
-0.8% 1.3% Higher Margin SIGA
Return on Equity (ROE)
Capital Efficiency
0.0% 0.4% Higher ROE SIGA
52-Week Range Position
Momentum
30% ($10–$19) 3% ($3–$7) Stronger Trend AAL
Beta / 30D Volatility
Risk Regime
1.82β · 52% Vol 0.75β · 65% Vol Lower Realized Risk AAL
Unified Institutional Score
Composite Signal
48.7 / 100 (HOLD) 47.5 / 100 (HOLD) Higher Composite AAL
Trailing 12M Revenue (USD)
Operating Scale
$61.0B $52M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
20.8% 23.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.21x PEG · 0.7x EV/Rev 3.37x PEG · 1.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$91M ($36.1B Net Debt) -$12M ($116M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AAL +19.02 pp
AAL: +3.96% · SIGA: -15.06%
3M Horizon AAL +4.87 pp
AAL: -7.96% · SIGA: -12.83%
6M Horizon AAL +37.34 pp
AAL: -6.4% · SIGA: -43.74%
1Y Horizon AAL +58.52 pp
AAL: +2.91% · SIGA: -55.61%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period AAL Revenue SIGA Revenue AAL Op. Margin SIGA Op. Margin Margin Leader
FY2018 $44.5B $480M 6.0% 74.4% SIGA
FY2019 $45.8B $30M 6.7% -8.7% AAL
FY2020 $17.3B $120M -60.1% 67.6% SIGA
FY2021 $29.9B $130M -3.5% 66.7% SIGA
FY2022 $49.0B $110M 3.3% 38.5% SIGA
FY2023 $52.8B $140M 5.7% 59.8% SIGA
FY2024 $54.2B $140M 4.8% 50.4% SIGA
FY2025 $54.6B $90M 2.7% 25.1% SIGA

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AAL BREAKDOWN
104d in phase · OBV DISTRIBUTION
Current IV 59.8%
IV Percentile 21st %ile
Put/Call OI Skew 1.38x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact AAL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SIGA CONSOLIDATION
33d in phase · OBV DISTRIBUTION
Current IV 81.4%
IV Percentile 8th %ile
Put/Call OI Skew 0.04x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact SIGA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $13.24 · IV 47.8%

AAL Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($1,324)

Compare $1,324 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 47.8% ATM IV.

5-DAY BULLISH SWING Liq A

Dec 18 $13 / $15 Bull Call Spread

Buy 1x $13C · Sell 1x $15C · 31d

Net Entry $67 Debit
T+5d @ +5% Move +$26 (+39%)
Max Risk / Buffer $67 Capped
5d Edge & Liquidity 0.9x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $12 / $11 Bull Put Spread

Sell 4x $12P · Buy 4x $11P · 31d

Net Entry $64 Credit
Max Credit / Yield +$64 (+19.0% RoM)
Max Risk / Buffer -10.6% Cushion ($336 Mgn)
5d Edge & Liquidity 77% PoP · Liq A
Simulate 5-Day Payoff →
5-DAY DOWNSIDE SPREAD Liq A

Dec 18 $14 / $12 Bear Put Spread

Buy 1x $14P · Sell 1x $12P · 31d

Net Entry $95 Debit
T+5d @ -5% Drop +$26 (+28%)
Max Risk / Buffer $95 Capped
5d Edge & Liquidity 0.8x R:R · Liq A
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AAL Moat Profile Cyclical / Execution-Driven Positioning
Airlines Operator
Competes within the Airlines value chain with $8.6B market capitalization and 1.8% operating margin.
OpEx & R&D Reinvestment 19.0% of Rev ($11.6B)
90D Engineering Disclosures 0 Published
SIGA Moat Profile Cyclical / Execution-Driven Positioning
Drug Manufacturers - Specialty & Generic Operator
Competes within the Drug Manufacturers - Specialty & Generic value chain with $187.9M market capitalization and -14.2% operating margin.
OpEx & R&D Reinvestment 37.6% of Rev ($20M)
90D Engineering Disclosures 0 Published

Investor FAQ AAL vs SIGA Key Questions & Quantitative Answers

As of Nov 19, 2026, American Airlines Group Inc. (AAL) captures the overall head-to-head institutional edge over SIGA Technologies Inc. (SIGA) on higher Unified Composite conviction (48.7/100 HOLD vs. 47.5/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples, Growth & Scale), while SIGA wins 4–2 across the 6-pillar growth and valuation breakdown. AAL trades at $12.72 (12.5x Forward P/E, 1.8% operating margin) versus SIGA at $2.65 (2.5x Forward P/E, -14.2% operating margin). Growth vs. Quality Trade-Off: AAL earns the overall head-to-head edge with a stronger Unified Composite Score (48.7/100 HOLD vs. SIGA 47.5/100 HOLD) and 1.82β · 52% Vol risk profile, whereas SIGA leads top-line expansion (-49.7% YoY revenue growth, 3.37x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: AAL is currently in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 46.6); meanwhile SIGA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AAL leads the Growth & Scale pillar: AAL posts +19.3% YoY revenue growth and -88.2% YoY earnings growth on $61.0B TTM revenue (20.8% gross margin, 1.8% operating margin), compared with SIGA at -49.7% YoY revenue growth and -65.3% YoY earnings growth on $52M TTM revenue (23.4% gross margin, -14.2% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), AAL cumulative revenue shifted +22.7% while SIGA shifted -81.2%. In operating R&D and SG&A reinvestment, AAL deploys 19.0% of Rev ($11.6B) (0 90-day corporate R&D disclosures) versus 37.6% of Rev ($20M) (0 disclosures) for SIGA.

AAL screens cheaper on headline valuation multiples. AAL trades at 12.5x Forward P/E, 11.1x Trailing P/E, 0.21x PEG, and 0.7x EV/Revenue (-0.1% FCF margin), whereas SIGA trades at 2.5x Forward P/E, N/M Trailing P/E, 3.37x PEG, and 1.4x EV/Revenue (-22.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AAL (0.0% ROE) versus SIGA (0.4% ROE) capital efficiency.

In options market volatility and institutional positioning, AAL carries 59.8% implied volatility (21st %ile, Compressed (<25th %ile)), a 1.38x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.82β · 52% Vol realized risk). By comparison, SIGA carries 81.4% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.04x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.75β · 65% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.